Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study Academic Article uri icon

Overview

MeSH Major

  • Anti-Obesity Agents
  • Caloric Restriction
  • Exercise Therapy
  • Glucagon-Like Peptide 1
  • Obesity
  • Weight Loss

abstract

  • Liraglutide, with diet and exercise, maintained weight loss achieved by caloric restriction and induced further weight loss over 56 weeks. Improvements in some cardiovascular disease-risk factors were also observed. Liraglutide, prescribed as 3.0 mg per day, holds promise for improving the maintenance of lost weight.

publication date

  • November 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ijo.2013.120

PubMed ID

  • 23812094

Additional Document Info

start page

  • 1443

end page

  • 51

volume

  • 37

number

  • 11